What is it about?
Fibroscan is a new non-invasive machine to measure liver stiffness measurement, which reflects the severity of liver fibrosis. This new tool can assist surgeons to predict the risk of liver failure after liver resection surgery.
Featured Image
Why is it important?
Fibroscan is better than all blood markers or imaging tests to predict major complications after liver resection surgery. It will become a new standard pre-operative assessment before liver resection surgery.
Perspectives
There are extensive validation studies on the use of Fibroscan to assess the severity of liver fibrosis in patients with various liver diseases. This paper relates the information of liver fibrosis to surgical outcome, hence creating a new indication for this machine in clinical practice. Future management guidelines should consider including Fibroscan as a standard assessment before any liver resection surgery.
Prof Henry LY Chan
Chinese University of Hong Kong
Read the Original
This page is a summary of: Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study, Journal of Gastroenterology and Hepatology, February 2017, Wiley,
DOI: 10.1111/jgh.13503.
You can read the full text:
Contributors
The following have contributed to this page
